Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 5.48% is 39% above its 5-year average of 3.94%, near the high end of its 5-year range (0.03%–6.28%).
As of the fiscal period ended Wednesday, December 31, 2025. 1.79% below its 12-month average of 5.58%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
5.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
5.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
5.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
3.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
3.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
5.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
7.13%
CURRENT VS TTM AVG
-1.79%
CURRENT VS 3Y AVG
+9.33%
CURRENT VS 5Y AVG
+39.09%
CURRENT VS 10Y AVG
+65.79%
CURRENT VS 15Y AVG
+4.97%
CURRENT VS 20Y AVG
-23.19%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-35.76%
vs the sector median at left
Zimmer Biomet Holdings, Inc.
Market Cap
$18.99B
Return on Invested Capital (ROIC)
5.48%
TTM Avg
5.58%
3Y Avg
5.01%
5Y Avg
3.94%
Market Cap
$20.55B
Return on Invested Capital (ROIC)
-7.95%
TTM Avg
-3.96%
3Y Avg
-1.19%
5Y Avg
-0.87%
Market Cap
$16.97B
Return on Invested Capital (ROIC)
7.35%
TTM Avg
8.59%
3Y Avg
9.78%
5Y Avg
13.56%
Market Cap
$16.41B
Return on Invested Capital (ROIC)
67.94%
TTM Avg
52.59%
3Y Avg
46.08%
5Y Avg
35.95%
Market Cap
$22.03B
Return on Invested Capital (ROIC)
16.13%
TTM Avg
15.79%
3Y Avg
14.56%
5Y Avg
13.09%
Market Cap
$22.32B
Return on Invested Capital (ROIC)
-29.70%
TTM Avg
-31.12%
3Y Avg
-12.69%
5Y Avg
0.19%
Market Cap
$22.68B
Return on Invested Capital (ROIC)
8.47%
TTM Avg
7.82%
3Y Avg
7.13%
5Y Avg
6.49%
Market Cap
$15.15B
Return on Invested Capital (ROIC)
17.76%
TTM Avg
12.30%
3Y Avg
11.68%
5Y Avg
9.70%
Market Cap
$23.16B
Return on Invested Capital (ROIC)
-3.14%
TTM Avg
-4.79%
3Y Avg
9.55%
5Y Avg
20.42%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc. (ZBH) | $18.99B | 5.48% | 5.58% | 5.01% | 3.94% |
| Viatris Inc. (VTRS)vs › | $20.55B | -7.95% | -3.96% | -1.19% | -0.87% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 7.35% | 8.59% | 9.78% | 13.56% |
| Medpace Holdings, Inc. (MEDP)vs › | $16.41B | 67.94% | 52.59% | 46.08% | 35.95% |
| United Therapeutics Corporation (UTHR)vs › | $22.03B | 16.13% | 15.79% | 14.56% | 13.09% |
| Moderna, Inc. (MRNA)vs › | $22.32B | -29.70% | -31.12% | -12.69% | 0.19% |
| STERIS plc (STE)vs › | $22.68B | 8.47% | 7.82% | 7.13% | 6.49% |
| Solventum Corporation (SOLV)vs › | $15.15B | 17.76% | 12.30% | 11.68% | 9.70% |
| BioNTech SE (BNTX)vs › | $23.16B | -3.14% | -4.79% | 9.55% | 20.42% |
| The Cooper Companies, Inc. (COO)vs › | $14.60B | 3.98% | 4.09% | 3.90% | 4.29% |
ROIC
5.5%
ROE
6.4%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 5.48% |
| 2024-12-31 | 5.68% |
| 2023-12-31 | 6.28% |
| 2022-12-31 | 2.61% |
| 2021-12-31 | 3.56% |
| 2020-12-31 | 0.03% |
| 2019-12-31 | 5.01% |
| 2018-12-31 | 0.15% |
| 2017-12-31 | 3.30% |
| 2016-12-31 | 2.51% |
| 2015-12-31 | 1.75% |
| 2014-12-31 | 9.22% |
| 2013-12-31 | 9.37% |
| 2012-12-31 | 9.66% |
| 2011-12-31 | 10.20% |
| 2010-12-31 | 8.72% |
| 2009-12-31 | 10.32% |
| 2008-12-31 | 12.76% |
| 2007-12-31 | 13.10% |
| 2006-12-31 | 15.57% |
| 2005-12-31 | 14.54% |
| 2004-12-31 | 11.26% |
| 2003-12-31 | 6.49% |
| 2002-12-31 | 43.23% |
| 2001-12-31 | 29.58% |
| 2000-12-31 | 42.87% |
| 1999-12-31 | 38.36% |
| 1998-12-31 | 0.00% |
